New smart sensors, which assist in the soft tissue balancing and correct positioning of an orthopaedic implant during hip replacement, are expected to prolong implant lifetimes and reduce the chances of patients needing difficult revision surgery.
vTv Therapeutics (NASDAQ:VTVT – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Wednesday, Zacks.com reports. The brokerage presently has a $0.50 price objective on the biotechnology company’s stock. Zacks Investment Research‘s price target would suggest a potential upside of 15.77% from the […]
vTv Therapeutics (NASDAQ:VTVT – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Thursday, Zacks.com reports. The firm currently has a $0.50 price target on the biotechnology company’s stock. Zacks Investment Research‘s price objective indicates a potential upside of 18.32% from the stock’s […]
vTv Therapeutics (NASDAQ:VTVT – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Tuesday, Zacks.com reports. The firm currently has a $0.75 price objective on the biotechnology company’s stock. Zacks Investment Research‘s price target suggests a potential upside of 17.19% […]